MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-28.3%
5Y CAGR+1.1%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-28.3%/yr
Annual compound
5Y CAGR
+1.1%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$11.43M+7.3%
2024$10.65M-53.5%
2023$22.92M-25.9%
2022$30.95M+66.3%
2021$18.61M+72.3%
2020$10.80M-53.0%
2019$22.97M-